Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW 1500 Grs or GA ≥33 Wks in Turkey. - Trial NCT06265363
Access comprehensive clinical trial information for NCT06265363 through Pure Global AI's free database. This phase not specified trial is sponsored by Baskent University Ankara Hospital and is currently Recruiting. The study focuses on Retinopathy of Prematurity. Target enrollment is 1000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Baskent University Ankara Hospital
Timeline & Enrollment
N/A
Aug 01, 2023
Nov 01, 2024
Primary Outcome
Incidence of ROP
Summary
The study includes preterm infants who are being screened for ROP between August 1,2023 and
 August 1, 2024 in 94 neonatal intensive care units (NICUs) in Turkey. Infants with birth
 weight (BW) of 1500 g or ≥ 33 weeks' gestation who are screened for retinopathy of
 prematurity are included. The incidence of any ROP, severe ROP and treatment modalities will
 be determined. The risk factors for ROP development will also be evaluated.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06265363
Non-Device Trial